Self-Controlled Case Series
Also known as: SCCS, Case Series Method, Within-Person Comparison Design, Farrington Method
The self-controlled case series, or SCCS, is a case-only study design for estimating the association between a transient exposure and an acute event by comparing each individual's event rate during exposed time windows with their rate during unexposed time windows. Developed by Paddy Farrington in 1995 for vaccine safety evaluation, it uses data only on people who experienced the outcome, and because each person serves as their own control, it automatically eliminates all fixed within-person confounders — genetics, sex, chronic conditions, socioeconomic position — without ever measuring them. A conditional Poisson likelihood removes the individual-level baseline rate and yields a relative incidence comparing risk to control periods. Whitaker, Farrington, Spiessens and Musonda's 2006 Statistics in Medicine tutorial is the standard practical guide to fitting and interpreting the model.
Key highlights
- Automatically controls all fixed within-person confounders, measured or not, because each case is their own control.
- Requires data on cases only, which is efficient and avoids the need to sample or measure a separate control group.
- Yields an easily interpreted within-person relative incidence comparing exposed to unexposed time.
- Has a well-developed likelihood framework with extensions for age adjustment, event-dependent exposure, and event-dependent observation.
Intuition
This section is available to Pro members. Upgrade to Pro
How it works
This section is available to Pro members. Upgrade to Pro
When to use it
Use the self-controlled case series when you are studying an acute, well-defined event in relation to a transient exposure, and you are worried about confounding by stable individual characteristics that are hard to measure — the canonical example being vaccine or drug safety, where exposed and unexposed people differ systematically. It is especially attractive when you have good data on cases and their exposure timing but lack a clean comparison group or reliable denominators for the unexposed. The design requires that events be relatively rare over the observation window, that the event not change the chance of future exposure, and that the event not terminate follow-up; when a fatal or recurrence-altering outcome violates these, modified SCCS variants or alternative designs are needed. It is less suitable for chronic exposures with no clear on-off timing, for outcomes that develop slowly, or when time-varying confounders other than age cannot be modeled.
Strengths & limitations
- Automatically controls all fixed within-person confounders, measured or not, because each case is their own control.
- Requires data on cases only, which is efficient and avoids the need to sample or measure a separate control group.
- Yields an easily interpreted within-person relative incidence comparing exposed to unexposed time.
- Has a well-developed likelihood framework with extensions for age adjustment, event-dependent exposure, and event-dependent observation.
- Controls only time-invariant confounders; time-varying confounders other than age must be modeled explicitly or they bias the estimate.
- Assumes the event is rare within the observation period, so that an event does not appreciably deplete subsequent time at risk.
- Standard SCCS assumes the event does not alter the probability of later exposure and does not end observation, which fails for some fatal or recurrence-blocking outcomes.
- Results are sensitive to the chosen risk-window definition, which must be pre-specified on mechanistic grounds rather than fitted to the data.
Common pitfalls
This section is available to Pro members. Upgrade to Pro
Applications
This section is available to Pro members. Upgrade to Pro
Frequently asked
Why does the SCCS only need data on cases?
The design compares exposed and unexposed time within each person who had the event, so the relevant contrast is internal to cases. By conditioning on the number of events each case experienced, the individual's baseline rate cancels out of the likelihood, and with it every fixed characteristic. Non-cases contribute no information about within-person timing, so they are simply not needed. Farrington's original derivation makes this explicit: the conditional likelihood depends only on the exposure status and length of each person's intervals, which is why the method is so efficient with case-only data.
What confounding does the SCCS handle, and what does it not?
It eliminates all confounders that are constant within a person over the observation period — sex, genetics, chronic comorbidity, stable socioeconomic factors — because these are absorbed into the conditioned-out baseline. It does not automatically handle time-varying confounders. The most important of these is age, which is modeled explicitly with age categories or splines; seasonality and other time trends must likewise be included if they move with exposure timing. Whitaker and colleagues stress that residual time-varying confounding is the main threat once fixed confounders are removed.
When do the SCCS assumptions break down?
Three assumptions matter most. First, events should be rare within the observation window so that having an event does not deplete later time at risk. Second, the event should not change the probability of subsequent exposure — for instance, if a reaction leads clinicians to withhold further doses, this event-dependent exposure biases the standard estimate. Third, the event should not end observation, as a fatal outcome does. Each violation has a tailored extension — pre-exposure windows, modified likelihoods for event-dependent exposure, and methods for event-dependent observation — described in the Whitaker tutorial, but the basic model should not be used when they hold without correction.
Sources
- 1.Farrington, C. P. (1995). Relative Incidence Estimation from Case Series for Vaccine Safety Evaluation. Biometrics, 51(1), 228-235.
- 2.Whitaker, H. J., Farrington, C. P., Spiessens, B., & Musonda, P. (2006). Tutorial in Biostatistics: The Self-Controlled Case Series Method. Statistics in Medicine, 25(10), 1768-1797.
You have read it. What now?
Cite this page
ScholarGate. (2026, June 23). Self-Controlled Case Series. ScholarGate. https://scholargate.app/social-epidemiology/self-controlled-case-series